Regarding the role of other LncRNAs, evidence has also been reported about the fact that the high expression of other LncRNAs such as maternally expressed gene 3 (MEG3), metastasis associated lung adenocarcinoma (MALAT1), cancer susceptibility candidate 2 (CASC2), taurine-upregulated gene 1 (TUG1), DBH antisense RNA 1 (DBH-AS1), AC005035.1, AC010336.2, AC108134.2, AC116351.2, Clorf132, C10orf91, LINC00475, MIR210HG could be associated with poor outcome in GBM cases (Zeng et al., 2018). The gene discussed is CASC2; the disease is glioblastoma.